Hasil Pencarian - Marcel Wacker

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics

    Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics oleh Marcel Wacker, Marcel Wacker, Marcel Wacker, Jens Bauer, Jens Bauer, Jens Bauer, Laura Wessling, Marissa Dubbelaar, Marissa Dubbelaar, Marissa Dubbelaar, Marissa Dubbelaar, Annika Nelde, Annika Nelde, Annika Nelde, Hans-Georg Rammensee, Hans-Georg Rammensee, Hans-Georg Rammensee, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia

    872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia oleh Hans-Georg Rammensee, Elke Schaeffeler, Matthias Schwab, Juliane S Walz, Jens Bauer, Marcel Wacker, Marissa Dubbelaar, Annika Nelde, Regina Bohnert, Jonas Scheid

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach

    1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach oleh Michael Weller, Luca Regli, Hans-Georg Rammensee, Juliane S Walz, Marian Christoph Neidert, Jens Bauer, Marcel Wacker, Gioele Medici, Marissa Dubbelaar, Annika Nelde, Friederike Hanssen, Carolin Schwitalla

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens

    iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens oleh Alexander Englisch, Alexander Englisch, Alexander Englisch, Clara Hayn, Clara Hayn, Susanne Jung, Susanne Jung, Susanne Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Marcel Wacker, Marcel Wacker, Monika Denk, Lisa Zieschang, Christine Kammer, Peter Martus, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

    TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification oleh Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, Lena Mühlenbruch, Sarah M. Schroeder, Marian C. Neidert, Jonas Scheid, Steffen Lemke, Marissa L. Dubbelaar, Marcel Wacker, Anna Dengler, Reinhild Klein, Paul-Stefan Mauz, Hubert Löwenheim, Mathias Hauri-Hohl, Roland Martin, Jörg Hennenlotter, Arnulf Stenzl, Jonas S. Heitmann, Helmut R. Salih, Hans-Georg Rammensee, Juliane S. Walz

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma oleh Jens Bauer, Natalie Köhler, Yacine Maringer, Philip Bucher, Tatjana Bilich, Melissa Zwick, Severin Dicks, Annika Nelde, Marissa Dubbelaar, Jonas Scheid, Marcel Wacker, Jonas S. Heitmann, Sarah Schroeder, Jonas Rieth, Monika Denk, Marion Richter, Reinhild Klein, Irina Bonzheim, Julia Luibrand, Ursula Holzer, Martin Ebinger, Ines B. Brecht, Michael Bitzer, Melanie Boerries, Judith Feucht, Helmut R. Salih, Hans-Georg Rammensee, Stephan Hailfinger, Juliane S. Walz

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

    Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency oleh Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M. Rittig, Christian M. Tegeler, Yacine Maringer, Simon U. Jaeger, Monika Denk, Marion Richter, Melek T. Oezbek, Karl-Heinz Wiesmüller, Jens Bauer, Jonas Rieth, Marcel Wacker, Sarah M. Schroeder, Naomi Hoenisch Gravel, Jonas Scheid, Melanie Märklin, Annika Henrich, Boris Klimovich, Kim L. Clar, Martina Lutz, Samuel Holzmayer, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W. Löffler, Caroline Anna Peuker, Stefan Habringer, Thorsten O. Goetze, Elke Jäger, Hans-Georg Rammensee, Helmut R. Salih, Juliane S. Walz

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: